The cost of Hemgenix, a one-time hemophilia B gene therapy, will be covered for patients living in Canada, except in Quebec.
Columnist Jennifer Lynne continues her series about 21-year-old film student Domenic Catrine, who received gene therapy for his hemophilia B.
Novo Nordisk has submitted an application to the FDA seeking approval of Mim8 for the treatment of people with hemophilia A.
Columnist G Shellye Horowitz used to be skeptical of AI, but a recent experience opened her eyes to the tool's potential in ...
Scientists have developed new versions of clotting factor IX, called FIX, that may be used to create personalized treatments for hemophilia B.
A stolen bike was a serious issue for columnist Joe MacDonald's son Caeleb, who has limited mobility. Joe stepped in to offer help.
MacDonald writes about what she imagined for her son, and how he embraced his life after a hemophilia diagnosis.
Columnist Allyx Formalejo and her husband, Jared, sometimes struggle to take a break, but rest is crucial for their health.
Researchers have developed new versions of clotting factor IX (FIX) that may be used to create personalized treatments for people with hemophilia B — specifically, new replacement therapies designed ...
When I was a young girl, I sat next to my father while he self-infused. I handed him his supplies — butterfly needles, syringes, alcohol, cotton, and medical tape — as he needed them. I watched every ...
Hemophilia is a blood disorder in which patients do not make enough of the clotting factors that control bleeding. Following accident or injury, people with hemophilia may be unable to stop bleeding.
Hemophilia is a blood disorder that is characterized by a shortage of specific clotting factors that help to form blood clots and stop bleeding. Historically, the primary treatment for hemophilia is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results